To explore the potential therapeutic impact of inhibiting lactate on reversing the responsiveness of Nur77‐mediated naïve CD8+ T cells in SCLC, the naïve CD8+ T cells were exposed to different treatment conditions, including a LAi. The gene discussed is NR4A1; the disease is small cell lung carcinoma.